LISA ROLLINS to Cell Line, Tumor
This is a "connection" page, showing publications LISA ROLLINS has written about Cell Line, Tumor.
Connection Strength
0.038
-
PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor. Mol Ther. 2011 Dec; 19(12):2133-43.
Score: 0.013
-
Attraction and activation of dendritic cells at the site of tumor elicits potent antitumor immunity. Mol Ther. 2009 Sep; 17(9):1626-36.
Score: 0.011
-
A broadly applicable, personalized heat shock protein-mediated oncolytic tumor vaccine. Cancer Res. 2003 Nov 01; 63(21):7321-9.
Score: 0.007
-
Human telomerase reverse transcriptase-specific T-helper responses induced by promiscuous major histocompatibility complex class II-restricted epitopes. Clin Cancer Res. 2003 Oct 15; 9(13):4743-55.
Score: 0.007